Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cumberland Pharmaceuticals (CPIX) Inventory: 2009-2024

Historic Inventory for Cumberland Pharmaceuticals (CPIX) over the last 16 years, with Dec 2024 value amounting to $4.0 million.

  • Cumberland Pharmaceuticals' Inventory fell 34.92% to $2.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.9 million, marking a year-over-year decrease of 34.92%. This contributed to the annual value of $4.0 million for FY2024, which is 13.22% down from last year.
  • Per Cumberland Pharmaceuticals' latest filing, its Inventory stood at $4.0 million for FY2024, which was down 13.22% from $4.6 million recorded in FY2023.
  • Cumberland Pharmaceuticals' Inventory's 5-year high stood at $10.6 million during FY2020, with a 5-year trough of $4.0 million in FY2024.
  • Its 3-year average for Inventory is $6.2 million, with a median of $4.6 million in 2023.
  • In the last 5 years, Cumberland Pharmaceuticals' Inventory grew by 19.92% in 2020 and then slumped by 53.27% in 2023.
  • Over the past 5 years, Cumberland Pharmaceuticals' Inventory (Yearly) stood at $10.6 million in 2020, then decreased by 20.76% to $8.4 million in 2021, then rose by 17.01% to $9.9 million in 2022, then crashed by 53.27% to $4.6 million in 2023, then declined by 13.22% to $4.0 million in 2024.